Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes.

J Allergy Clin Immunol Glob · 2026 · PMC13213748 · PMID 42211875

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although most comparisons did not reach statistical significance owing to the small sample size, directional reductions in symptom and medication scores were observed.

also in 111,027 other papers

showed a trendno p-value reported

Despite nearly triple pollen exposure in 2025 compared with 2024 (2850.6 vs 960.3 grains/cm 2 ) ( Fig 1 ), nasal and ocular symptom scores in patients with RA showed a trend toward improvement compared with those in 2024, with reductions of approximately 30% to 60%.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.